首页 > 最新文献

Pediatric Gastroenterology, Hepatology & Nutrition最新文献

英文 中文
Clinician Experience with Using Hypoallergenic Formulas to Treat Infants with Suspected Cow's Milk Protein Allergy: A Secondary Analysis of a Prospective Survey Cohort. 临床医生使用低致敏配方奶粉治疗疑似牛奶蛋白过敏婴儿的经验:前瞻性调查队列的二次分析。
IF 1.9 Q2 Medicine Pub Date : 2023-09-01 DOI: 10.5223/pghn.2023.26.5.277
Jesse Beacker, Jerry M Brown, Jared Florio, Jessica V Baran, Luke Lamos, Lea Oliveros, Jon A Vanderhoof, Panida Sriaroon, Michael J Wilsey

Purpose: Cow's milk protein allergy (CMPA) is a common condition in infants, but little is known about healthcare providers' clinical experience treating infants with CMPA. To address this gap, we analyzed prospectively collected data from healthcare providers (HCPs) who treated infants under six months old with suspected CMPA using hypoallergenic formulas. The study focused on a commercial extensively hydrolyzed formula containing Lactobacillus rhamnosus GG (ATCC53103) (eHF-LGG) or a commercial amino acid formula (AAF).

Methods: In this secondary analysis of prospectively collected survey data, 52 HCPs treated 329 infants under six months old with suspected CMPA using hypoallergenic formulas. A series of two de-identified surveys per patient were collected by HCPs to assess short-term symptom relief in the patients and HCP's satisfaction with the management strategies. The initial survey was completed at the initiation of treatment of CMPA, and the second survey was completed at a follow-up visit.

Results: The majority of HCPs (87%) in the study were general pediatricians, and most saw 2 to 10 CMPA patients weekly. Results showed that clinicians reported satisfaction with treatment in 95% of patients in the EHF cohort and 97% of patients in the AAF cohort and achieved expected clinical results in 93% and 97% of patients using eHF and AAF, respectively. Furthermore, few patients were switched from the hypoallergenic formula once initiated.

Conclusion: The study provides new insights into HCP perspectives on treating infants with CMPA and supports using hypoallergenic formulas to manage this condition. However, additional prospective controlled studies are needed to confirm these initial findings.

目的:牛奶蛋白过敏(CMPA)是婴儿的常见疾病,但对医疗保健提供者治疗CMPA婴儿的临床经验知之甚少。为了解决这一差距,我们分析了医疗保健提供者(HCP)前瞻性收集的数据,这些提供者使用低过敏性配方奶粉治疗六个月以下疑似CMPA的婴儿。该研究的重点是含有鼠李糖乳杆菌GG(ATCC53103)(eHF LGG)的商业广泛水解配方奶粉或商业氨基酸配方奶粉(AAF)。方法:在对前瞻性收集的调查数据进行的二次分析中,52名HCP使用低致敏配方奶粉治疗了329名6个月以下疑似CMPA的婴儿。HCP为每位患者收集了一系列两项未确定的调查,以评估患者的短期症状缓解情况以及HCP对管理策略的满意度。首次调查在CMPA治疗开始时完成,第二次调查在随访时完成。结果:研究中的大多数HCP(87%)是普通儿科医生,大多数HCP每周看2到10名CMPA患者。结果显示,临床医生报告EHF队列中95%的患者和AAF队列中97%的患者对治疗感到满意,使用EHF和AAF的患者分别达到93%和97%的预期临床结果。此外,很少有患者在开始使用低致敏配方奶粉后就放弃了。结论:该研究为HCP治疗CMPA婴儿的观点提供了新的见解,并支持使用低致敏配方奶粉来治疗这种情况。然而,还需要更多的前瞻性对照研究来证实这些初步发现。
{"title":"Clinician Experience with Using Hypoallergenic Formulas to Treat Infants with Suspected Cow's Milk Protein Allergy: A Secondary Analysis of a Prospective Survey Cohort.","authors":"Jesse Beacker,&nbsp;Jerry M Brown,&nbsp;Jared Florio,&nbsp;Jessica V Baran,&nbsp;Luke Lamos,&nbsp;Lea Oliveros,&nbsp;Jon A Vanderhoof,&nbsp;Panida Sriaroon,&nbsp;Michael J Wilsey","doi":"10.5223/pghn.2023.26.5.277","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.5.277","url":null,"abstract":"<p><strong>Purpose: </strong>Cow's milk protein allergy (CMPA) is a common condition in infants, but little is known about healthcare providers' clinical experience treating infants with CMPA. To address this gap, we analyzed prospectively collected data from healthcare providers (HCPs) who treated infants under six months old with suspected CMPA using hypoallergenic formulas. The study focused on a commercial extensively hydrolyzed formula containing Lactobacillus rhamnosus GG (ATCC53103) (eHF-LGG) or a commercial amino acid formula (AAF).</p><p><strong>Methods: </strong>In this secondary analysis of prospectively collected survey data, 52 HCPs treated 329 infants under six months old with suspected CMPA using hypoallergenic formulas. A series of two de-identified surveys per patient were collected by HCPs to assess short-term symptom relief in the patients and HCP's satisfaction with the management strategies. The initial survey was completed at the initiation of treatment of CMPA, and the second survey was completed at a follow-up visit.</p><p><strong>Results: </strong>The majority of HCPs (87%) in the study were general pediatricians, and most saw 2 to 10 CMPA patients weekly. Results showed that clinicians reported satisfaction with treatment in 95% of patients in the EHF cohort and 97% of patients in the AAF cohort and achieved expected clinical results in 93% and 97% of patients using eHF and AAF, respectively. Furthermore, few patients were switched from the hypoallergenic formula once initiated.</p><p><strong>Conclusion: </strong>The study provides new insights into HCP perspectives on treating infants with CMPA and supports using hypoallergenic formulas to manage this condition. However, additional prospective controlled studies are needed to confirm these initial findings.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/75/pghn-26-277.PMC10509022.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41126369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anxiety, Depression, and Quality of Life in Parents of Adolescents with Inflammatory Bowel Disease: A Longitudinal Study. 炎症性肠病青少年父母的焦虑、抑郁和生活质量:一项纵向研究。
IF 1.9 Q2 Medicine Pub Date : 2023-09-01 DOI: 10.5223/pghn.2023.26.5.239
Satomi Nomura, Yuri Hirano, Ichiro Takeuchi, Hirotaka Shimizu, Katsuhiro Arai

Purpose: The parents of adolescents with inflammatory bowel disease may experience impaired mental health and quality of life. This longitudinal study aimed to verify whether the mental health and quality of life of the parents of adolescents with inflammatory bowel disease declined when their children had active disease.

Methods: Sociodemographic data, parental anxiety, depression, and quality of life were analyzed using validated questionnaires for each variable. After the baseline survey, the second and follow-up surveys were conducted at 3 and 12 months, respectively. The active disease group comprised eight parents whose children had active disease during the baseline and second surveys. The remission group comprised 14 parents whose children remained in remission during both surveys. The improved group comprised nine parents whose children experienced active disease at baseline and remission during the second survey. Parental mental health and quality of life were compared among the groups.

Results: Significantly higher levels of anxiety were observed in the active disease group in all surveys (p<0.050). Although depression levels and quality of life did not differ significantly among the three groups, pairing the active disease group with other groups showed some large effect sizes.

Conclusion: Parents tended to experience decreased mental health and quality of life when their adolescents experienced active inflammatory bowel disease. Consequently, our hypothesis was partially verified. Therefore, parents need support when their children have active disease; this finding highlights the need for parental support systems.

目的:患有炎症性肠病的青少年的父母可能会经历心理健康和生活质量受损。这项纵向研究旨在验证患有炎症性肠病的青少年父母的心理健康和生活质量在其子女患有活动性疾病时是否有所下降。方法:使用每个变量的有效问卷对社会形态数据、父母焦虑、抑郁和生活质量进行分析。基线调查后,分别在3个月和12个月进行第二次和后续调查。活动性疾病组由八名父母组成,他们的孩子在基线调查和第二次调查期间患有活动性疾病。缓解组包括14名父母,他们的孩子在两次调查中都处于缓解状态。改进组包括9名父母,他们的孩子在基线时经历了活动性疾病,并在第二次调查中病情缓解。比较各组父母的心理健康和生活质量。结果:在所有调查中,活动性疾病组的焦虑水平明显更高(结论:当青少年患有活动性炎症性肠病时,父母的心理健康和生活质量往往会下降。因此,我们的假设得到了部分验证。因此,当孩子患有活动性疾病时,父母需要支持;这一发现突出了父母支持系统的必要性。)。
{"title":"Anxiety, Depression, and Quality of Life in Parents of Adolescents with Inflammatory Bowel Disease: A Longitudinal Study.","authors":"Satomi Nomura,&nbsp;Yuri Hirano,&nbsp;Ichiro Takeuchi,&nbsp;Hirotaka Shimizu,&nbsp;Katsuhiro Arai","doi":"10.5223/pghn.2023.26.5.239","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.5.239","url":null,"abstract":"<p><strong>Purpose: </strong>The parents of adolescents with inflammatory bowel disease may experience impaired mental health and quality of life. This longitudinal study aimed to verify whether the mental health and quality of life of the parents of adolescents with inflammatory bowel disease declined when their children had active disease.</p><p><strong>Methods: </strong>Sociodemographic data, parental anxiety, depression, and quality of life were analyzed using validated questionnaires for each variable. After the baseline survey, the second and follow-up surveys were conducted at 3 and 12 months, respectively. The active disease group comprised eight parents whose children had active disease during the baseline and second surveys. The remission group comprised 14 parents whose children remained in remission during both surveys. The improved group comprised nine parents whose children experienced active disease at baseline and remission during the second survey. Parental mental health and quality of life were compared among the groups.</p><p><strong>Results: </strong>Significantly higher levels of anxiety were observed in the active disease group in all surveys (<i>p</i><0.050). Although depression levels and quality of life did not differ significantly among the three groups, pairing the active disease group with other groups showed some large effect sizes.</p><p><strong>Conclusion: </strong>Parents tended to experience decreased mental health and quality of life when their adolescents experienced active inflammatory bowel disease. Consequently, our hypothesis was partially verified. Therefore, parents need support when their children have active disease; this finding highlights the need for parental support systems.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/c2/pghn-26-239.PMC10509017.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41179602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Milk Oligosaccharide Profiles and the Secretor and Lewis Gene Status of Indonesian Lactating Mothers. 母乳低聚糖图谱与印尼哺乳母亲的分泌子和Lewis基因状况。
IF 1.9 Q2 Medicine Pub Date : 2023-09-01 DOI: 10.5223/pghn.2023.26.5.266
Verawati Sudarma, Diana Sunardi, Nanis Sacharina Marzuki, Zakiudin Munasir, Asmarinah, Adi Hidayat, Badriul Hegar

Purpose: Human milk oligosaccharides (HMOs) may be genetically determined based on the secretor and Lewis status of the mother. This study aims to determine the HMO profile and the secretor and Lewis gene status of Indonesian lactating mothers.

Methods: Baseline data of 120 mother-infant pairs between 0-4 months post-partum obtained from a prospective longitudinal study was used. The concentrations of 2'-fucosyllactose (2'FL), lacto-N-fucopentaose I (LNFP I), lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), 3'-sialyllactose (3'SL), and 6'-sialyllactose (6'SL) were measured. Genetic analysis was performed for mothers using targeted next-generation sequencing and Sanger sequencing. Wild-type AA with the rs1047781 (A385T) polymorphism was categorized as secretor positive, while heterozygous mutant AT was classified as a weak secretor. The presence of rs28362459 (T59G) heterozygous mutant AC and rs3745635 (G508A) heterozygous mutant CT genes indicated a Lewis negative status, and the absence of these genes indicated a positive status. Subsequently, breast milk was classified into various groups, namely Group 1: Secretor+Lewis+ (Se+Le+), Group 2: Secretor-Lewis+ (Se-Le+), Group 3: Secretor+Lewis- (Se+Le-), and Group 4: Secretor-Lewis- (Se-Le-). Data were analyzed using the Mann-Whitney and Kruskal-Wallis rank tests, and a p-value of 0.05 indicated statistical significance.

Results: A total of 58.3% and 41.7% of the samples had positive and weak secretor statuses, respectively. The proportion of those in Group 1 was 85%, while 15% were Group 3. The results showed that only 2'FL significantly differed according to the secretor status (p-value=0.018).

Conclusion: All Indonesian lactating mothers in this study were secretor positive, and most of them had a Lewis-positive status.

目的:母乳低聚糖(HMO)可以根据母亲的分泌和Lewis状态进行基因测定。本研究旨在确定印尼哺乳期母亲的HMO图谱、分泌子和Lewis基因状况。方法:采用前瞻性纵向研究获得的120对产后0-4个月母婴的基线数据。测量2'-岩藻糖基乳糖(2'FL)、乳糖-N-岩藻五糖I(LNFP I)、乳糖-N四糖(LNT)、乳糖N-新四糖(LNnT)、3'-唾液乳糖(3'SL)和6'-唾液乳糖(6'SL)的浓度。使用靶向下一代测序和Sanger测序对母亲进行基因分析。具有rs1047781(A385T)多态性的野生型AA被归类为分泌型阳性,而杂合突变AT被归类为弱分泌型。rs28362459(T59G)杂合突变体AC和rs3745635(G508A)杂合突变CT基因的存在表明Lewis阴性状态,而这些基因的缺失表明阳性状态。随后,母乳被分为不同的组,即第1组:分泌物+路易斯+(Se+Le+),第2组:分泌器-路易斯+(硒-乐+)、第3组:分泌者+路易斯-(硒+乐-)和第4组:分泌体-路易斯-(Se-乐-)。使用Mann-Whitney和Kruskal-Wallis秩检验对数据进行分析,p值为0.05表示具有统计学意义。结果:共有58.3%和41.7%的样本具有阳性和弱分泌状态。第1组的比例为85%,第3组为15%。结果显示,根据分泌状态,只有2'FL存在显著差异(p值=0.018)。结论:本研究中所有印尼哺乳期母亲均为分泌阳性,其中大多数为Lewis阳性。
{"title":"Human Milk Oligosaccharide Profiles and the Secretor and Lewis Gene Status of Indonesian Lactating Mothers.","authors":"Verawati Sudarma,&nbsp;Diana Sunardi,&nbsp;Nanis Sacharina Marzuki,&nbsp;Zakiudin Munasir,&nbsp;Asmarinah,&nbsp;Adi Hidayat,&nbsp;Badriul Hegar","doi":"10.5223/pghn.2023.26.5.266","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.5.266","url":null,"abstract":"<p><strong>Purpose: </strong>Human milk oligosaccharides (HMOs) may be genetically determined based on the secretor and Lewis status of the mother. This study aims to determine the HMO profile and the secretor and Lewis gene status of Indonesian lactating mothers.</p><p><strong>Methods: </strong>Baseline data of 120 mother-infant pairs between 0-4 months post-partum obtained from a prospective longitudinal study was used. The concentrations of 2'-fucosyllactose (2'FL), lacto-N-fucopentaose I (LNFP I), lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), 3'-sialyllactose (3'SL), and 6'-sialyllactose (6'SL) were measured. Genetic analysis was performed for mothers using targeted next-generation sequencing and Sanger sequencing. Wild-type AA with the rs1047781 (A385T) polymorphism was categorized as secretor positive, while heterozygous mutant AT was classified as a weak secretor. The presence of rs28362459 (T59G) heterozygous mutant AC and rs3745635 (G508A) heterozygous mutant CT genes indicated a Lewis negative status, and the absence of these genes indicated a positive status. Subsequently, breast milk was classified into various groups, namely Group 1: Secretor+Lewis+ (Se+Le+), Group 2: Secretor-Lewis+ (Se-Le+), Group 3: Secretor+Lewis- (Se+Le-), and Group 4: Secretor-Lewis- (Se-Le-). Data were analyzed using the Mann-Whitney and Kruskal-Wallis rank tests, and a <i>p</i>-value of 0.05 indicated statistical significance.</p><p><strong>Results: </strong>A total of 58.3% and 41.7% of the samples had positive and weak secretor statuses, respectively. The proportion of those in Group 1 was 85%, while 15% were Group 3. The results showed that only 2'FL significantly differed according to the secretor status (<i>p</i>-value=0.018).</p><p><strong>Conclusion: </strong>All Indonesian lactating mothers in this study were secretor positive, and most of them had a Lewis-positive status.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a1/19/pghn-26-266.PMC10509021.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41176900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Primary Prophylaxis to Prevent Bleeding in Children with Esophageal Varices: A Systematic Review and Meta-Analysis. 内镜下预防儿童食管静脉曲张出血的一级预防措施:系统综述和荟萃分析。
IF 1.9 Q2 Medicine Pub Date : 2023-09-01 DOI: 10.5223/pghn.2023.26.5.231
Fatima Safira Alatas, Ervin Monica, Lukito Ongko, Muzal Kadim

Purpose: This systematic review and meta-analysis aimed to compare endoscopy as primary versus secondary prophylaxis to prevent future bleeding in children with esophageal varices.

Methods: A systematic literature search using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses method was conducted using the Scopus, PubMed, and Cochrane databases for relevant studies on the outcome of rebleeding events after endoscopy in primary prophylaxis compared to that in secondary prophylaxis. The following keywords were used: esophageal varices, children, endoscopy, primary prophylaxis and bleeding. The quality of eligible articles was assessed using the Newcastle-Ottawa Scale and statistically analyzed using RevMan 5.4 software.

Results: A total of 174 children were included from four eligible articles. All four studies were considered of high-quality based on the Newcastle-Ottawa Quality Assessment Scale. Patients who received primary prophylaxis had 79% lower odds of bleeding than those who received secondary prophylaxis (odds ratio, 0.21; 95% confidence interval [CI], 0.07-0.66; I2=0%, p=0.008). Patients in the primary prophylaxis group underwent fewer endoscopic procedures to eradicate varices than those in the secondary prophylaxis group, with a mean difference of 1.73 (95% CI, 0.91-2.56; I2=62%, p<0.0001).

Conclusion: Children with high-risk varices who underwent primary prophylaxis were less likely to experience future bleeding episodes and required fewer endoscopic procedures to eradicate the varices than children who underwent secondary prophylaxis.

目的:本系统综述和荟萃分析旨在比较内镜作为预防儿童食管静脉曲张破裂出血的一级预防和二级预防。方法:使用Scopus、PubMed和Cochrane数据库,使用系统评价和荟萃分析的首选报告项目方法进行系统文献检索,以进行一级预防与二级预防内镜下再出血事件结果的相关研究。使用了以下关键词:食道静脉曲张、儿童、内窥镜检查、初级预防和出血。合格文章的质量使用Newcastle Ottawa量表进行评估,并使用RevMan 5.4软件进行统计分析。结果:共有174名儿童被纳入四篇符合条件的文章。根据纽卡斯尔-渥太华质量评估量表,所有四项研究都被认为是高质量的。接受初级预防的患者出血的几率比接受二级预防的患者低79%(比值比,0.21;95%置信区间[CI],0.07-0.66;I2=0%,p=0.008)。初级预防组的患者比二级预防组少接受内镜手术根除静脉曲张,平均差异为1.73(95%CI,0.91-2.56;I2=62%,P结论:与接受二级预防的儿童相比,接受一级预防的高危静脉曲张儿童未来出血的可能性较小,需要较少的内镜手术来根除静脉曲张。
{"title":"Endoscopic Primary Prophylaxis to Prevent Bleeding in Children with Esophageal Varices: A Systematic Review and Meta-Analysis.","authors":"Fatima Safira Alatas,&nbsp;Ervin Monica,&nbsp;Lukito Ongko,&nbsp;Muzal Kadim","doi":"10.5223/pghn.2023.26.5.231","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.5.231","url":null,"abstract":"<p><strong>Purpose: </strong>This systematic review and meta-analysis aimed to compare endoscopy as primary versus secondary prophylaxis to prevent future bleeding in children with esophageal varices.</p><p><strong>Methods: </strong>A systematic literature search using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses method was conducted using the Scopus, PubMed, and Cochrane databases for relevant studies on the outcome of rebleeding events after endoscopy in primary prophylaxis compared to that in secondary prophylaxis. The following keywords were used: esophageal varices, children, endoscopy, primary prophylaxis and bleeding. The quality of eligible articles was assessed using the Newcastle-Ottawa Scale and statistically analyzed using RevMan 5.4 software.</p><p><strong>Results: </strong>A total of 174 children were included from four eligible articles. All four studies were considered of high-quality based on the Newcastle-Ottawa Quality Assessment Scale. Patients who received primary prophylaxis had 79% lower odds of bleeding than those who received secondary prophylaxis (odds ratio, 0.21; 95% confidence interval [CI], 0.07-0.66; I<sup>2</sup>=0%, <i>p</i>=0.008). Patients in the primary prophylaxis group underwent fewer endoscopic procedures to eradicate varices than those in the secondary prophylaxis group, with a mean difference of 1.73 (95% CI, 0.91-2.56; I<sup>2</sup>=62%, <i>p</i><0.0001).</p><p><strong>Conclusion: </strong>Children with high-risk varices who underwent primary prophylaxis were less likely to experience future bleeding episodes and required fewer endoscopic procedures to eradicate the varices than children who underwent secondary prophylaxis.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/01/5b/pghn-26-231.PMC10509019.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Small Bowel Transit Time for Capsule Endoscopy in Children with Inflammatory Bowel Disease. 炎症性肠病儿童胶囊内窥镜检查小肠运输时间的预测因素。
IF 1.9 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.5223/pghn.2023.26.4.181
Itsuhiro Oka, Rie Funayama, Hirotaka Shimizu, Ichiro Takeuchi, Shuko Nojiri, Toshiaki Shimizu, Katsuhiro Arai

Purpose: The development of assistive devices has allowed for the performance of capsule endoscopy in children. Anticipating the capsule's transit time could affect the efficacy of the investigation and potentially minimize the fasting period. This study determined the predictors of small bowel transit time for small-bowel capsule endoscopy in children and adolescents with inflammatory bowel disease.

Methods: We retrospectively examined children and adolescents with inflammatory bowel disease who underwent capsule endoscopy by the age 18 at a Japanese tertiary care children's hospital. Small bowel transit time predictors were analyzed using multiple regression with explanatory variables.

Results: Overall, 92 patients, aged 1-17 years, with inflammatory bowel disease (63 Crohn's disease and 29 ulcerative colitis cases) were examined for factors affecting small bowel transit time. In the simple regression analysis, diagnosis, age, height, weight, serum albumin, general anesthesia, and small intestine lesions were significantly associated with small bowel transit time. In the multiple regression analyses, serum albumin (partial regression coefficient: -58.9, p=0.008), general anesthesia (partial regression coefficient: 127, p<0.001), and small intestine lesions (partial regression coefficient: 30.1, p=0.037) showed significant associations with small bowel transit time.

Conclusion: Hypoalbuminemia, the use of general anesthesia for endoscopic delivery of the capsule, and small intestine lesions appeared to be predictors of prolonged small bowel transit time in children and adolescents with inflammatory bowel disease. Expecting the finishing time may improve examination with a fasting period reduction, which benefits both patients and caregivers.

目的:辅助装置的发展使儿童胶囊内窥镜检查的性能成为可能。预测胶囊的运输时间可能会影响调查的有效性,并可能最大限度地减少禁食时间。本研究确定了患有炎症性肠病的儿童和青少年进行小肠胶囊内窥镜检查时小肠运输时间的预测因素。方法:我们回顾性研究了在日本一家三级保健儿童医院接受胶囊内窥镜检查的18岁以下患有炎症性肠病的儿童和青少年。采用带解释变量的多元回归分析小肠运输时间预测因子。结果:总体而言,92例1-17岁炎症性肠病患者(63例克罗恩病和29例溃疡性结肠炎)接受了影响小肠运输时间的因素检查。在简单回归分析中,诊断、年龄、身高、体重、血清白蛋白、全身麻醉、小肠病变与小肠运输时间显著相关。在多元回归分析中,血清白蛋白(部分回归系数:-58.9,p=0.008)、全身麻醉(部分回归系数:127,p0.001)和小肠病变(部分回归系数:30.1,p=0.037)与小肠运输时间有显著相关性。结论:在患有炎症性肠病的儿童和青少年中,低白蛋白血症、全麻内镜下给药和小肠病变似乎是小肠运输时间延长的预测因素。预期结束时间可以改善检查,减少禁食期,这对患者和护理人员都有利。
{"title":"Predictors of Small Bowel Transit Time for Capsule Endoscopy in Children with Inflammatory Bowel Disease.","authors":"Itsuhiro Oka,&nbsp;Rie Funayama,&nbsp;Hirotaka Shimizu,&nbsp;Ichiro Takeuchi,&nbsp;Shuko Nojiri,&nbsp;Toshiaki Shimizu,&nbsp;Katsuhiro Arai","doi":"10.5223/pghn.2023.26.4.181","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.4.181","url":null,"abstract":"<p><strong>Purpose: </strong>The development of assistive devices has allowed for the performance of capsule endoscopy in children. Anticipating the capsule's transit time could affect the efficacy of the investigation and potentially minimize the fasting period. This study determined the predictors of small bowel transit time for small-bowel capsule endoscopy in children and adolescents with inflammatory bowel disease.</p><p><strong>Methods: </strong>We retrospectively examined children and adolescents with inflammatory bowel disease who underwent capsule endoscopy by the age 18 at a Japanese tertiary care children's hospital. Small bowel transit time predictors were analyzed using multiple regression with explanatory variables.</p><p><strong>Results: </strong>Overall, 92 patients, aged 1-17 years, with inflammatory bowel disease (63 Crohn's disease and 29 ulcerative colitis cases) were examined for factors affecting small bowel transit time. In the simple regression analysis, diagnosis, age, height, weight, serum albumin, general anesthesia, and small intestine lesions were significantly associated with small bowel transit time. In the multiple regression analyses, serum albumin (partial regression coefficient: -58.9, <i>p=</i>0.008), general anesthesia (partial regression coefficient: 127, <i>p<</i>0.001), and small intestine lesions (partial regression coefficient: 30.1, <i>p=</i>0.037) showed significant associations with small bowel transit time.</p><p><strong>Conclusion: </strong>Hypoalbuminemia, the use of general anesthesia for endoscopic delivery of the capsule, and small intestine lesions appeared to be predictors of prolonged small bowel transit time in children and adolescents with inflammatory bowel disease. Expecting the finishing time may improve examination with a fasting period reduction, which benefits both patients and caregivers.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/66/pghn-26-181.PMC10356975.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9918955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients. 证实巨细胞病毒结肠炎与两名儿童异基因造血干细胞移植受者给予达沙替尼相关。
IF 1.9 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.5223/pghn.2023.26.4.224
Jeong Min Kim, Hyun Mi Kang, In Hyuk Yoo, Dong-Gun Lee, Nack-Gyun Chung, Bin Cho

Gastrointestinal (GI) bleeding is a rare adverse event of dasatinib, which is known to be caused by dasatinib-induced colitis, severe thrombocytopenia, and platelet dysfunction. We present two cases of pediatric patients who developed hematochezia during treatment with dasatinib after hematopoietic stem cell transplantation (HSCT). A colonic tissue biopsy was performed to differentiate the cause of GI bleeding. Both patients were diagnosed with proven cytomegalovirus (CMV) colitis, but only one was treated with ganciclovir. The patient who did not receive antiviral therapy experienced recurrent GI bleeding during dasatinib administration, leading to multiple treatment interruptions. During dasatinib therapy after HSCT, patients with GI bleeding and confirmed CMV colitis may benefit from antiviral therapy to reduce interruptions in dasatinib therapy.

胃肠道(GI)出血是达沙替尼罕见的不良事件,已知是由达沙替尼诱导的结肠炎、严重的血小板减少症和血小板功能障碍引起的。我们报告了两例在造血干细胞移植(HSCT)后使用达沙替尼治疗期间发生便血的儿科患者。进行结肠组织活检以鉴别消化道出血的原因。两名患者均确诊为巨细胞病毒(CMV)结肠炎,但只有一名患者接受了更昔洛韦治疗。未接受抗病毒治疗的患者在使用达沙替尼期间出现复发性胃肠道出血,导致多次治疗中断。在HSCT后的达沙替尼治疗期间,胃肠道出血和确诊巨细胞病毒性结肠炎的患者可能受益于抗病毒治疗,以减少达沙替尼治疗的中断。
{"title":"Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.","authors":"Jeong Min Kim,&nbsp;Hyun Mi Kang,&nbsp;In Hyuk Yoo,&nbsp;Dong-Gun Lee,&nbsp;Nack-Gyun Chung,&nbsp;Bin Cho","doi":"10.5223/pghn.2023.26.4.224","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.4.224","url":null,"abstract":"<p><p>Gastrointestinal (GI) bleeding is a rare adverse event of dasatinib, which is known to be caused by dasatinib-induced colitis, severe thrombocytopenia, and platelet dysfunction. We present two cases of pediatric patients who developed hematochezia during treatment with dasatinib after hematopoietic stem cell transplantation (HSCT). A colonic tissue biopsy was performed to differentiate the cause of GI bleeding. Both patients were diagnosed with proven cytomegalovirus (CMV) colitis, but only one was treated with ganciclovir. The patient who did not receive antiviral therapy experienced recurrent GI bleeding during dasatinib administration, leading to multiple treatment interruptions. During dasatinib therapy after HSCT, patients with GI bleeding and confirmed CMV colitis may benefit from antiviral therapy to reduce interruptions in dasatinib therapy.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/37/pghn-26-224.PMC10356971.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9865161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of Nutritional Screening Tools Versus Anthropometric Measurements in Evaluating Nutritional Status of Children in a Low/Middle-Income Country. 营养筛查工具与人体测量在评估中低收入国家儿童营养状况中的价值
IF 1.9 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.5223/pghn.2023.26.4.213
Shaimaa Sayed, Mortada H F El-Shabrawi, Eman Abdelmonaem, Nehal El Koofy, Sara Tarek

Purpose: Pediatric patients in low-income countries are at a high risk of malnutrition. Numerous screening tools have been developed to detect the risk of malnutrition, including the Subjective Global Nutritional Assessment (SGNA), Pediatric Yorkhill Malnutrition Score (PYMS), Screening Tool for the Assessment of Malnutrition in Pediatrics (STAMP), and Screening Tool for Risk of Nutritional Status and Growth (STRONGkids). However, anthropometry remains the main tool for assessing malnutrition. We aimed to identify the value of four nutritional screening tools versus anthropometry for evaluating the nutritional status of children.

Methods: We conducted a cross-sectional study of 1,000 children aged 1-12 years who visited the outpatient clinic of Cairo University Pediatric Hospital. Each participant was evaluated using anthropometric measurements (weight, length/height, and weight for length/height) as well as the PYMS, STAMP, STRONGkids, and SGNA screening tools. The sensitivities and specificities of these four tools were assessed using anthropometry as the gold standard.

Results: Of the patients, 1.7% were underweight, 10.2% were wasted, and 35% were stunted. STRONGkids demonstrated the highest sensitivity (79.4%) and a high specificity (80.2%) for detecting malnutrition compared with weight for height, followed by STAMP, which demonstrated lower sensitivity (73.5%) but higher specificity (81.4%). PYMS demonstrated the lowest sensitivity (66.7%) and the highest specificity (93.5%), whereas SAGA demonstrated higher sensitivity (77.5%) and lower specificity (85.4%) than PYMS.

Conclusion: The use of nutritional screening tools to evaluate the nutritional status of children is valuable and recommended as a simple and rapid method for identifying the risk of malnutrition in pediatric patients.

目的:低收入国家的儿科患者营养不良的风险很高。已经开发了许多筛查工具来检测营养不良的风险,包括主观全球营养评估(SGNA)、儿科约克希尔营养不良评分(PYMS)、儿科营养不良评估筛查工具(STAMP)和营养状况和生长风险筛查工具(STRONGkids)。然而,人体测量仍然是评估营养不良的主要工具。我们的目的是确定四种营养筛查工具与人体测量法在评估儿童营养状况方面的价值。方法:我们对开罗大学儿科医院门诊就诊的1000名1-12岁儿童进行了横断面研究。使用人体测量(体重、长度/高度和体重/长度/高度)以及PYMS、STAMP、STRONGkids和SGNA筛选工具对每位参与者进行评估。以人体测量作为金标准,对这四种工具的敏感性和特异性进行了评估。结果:体重不足占1.7%,消瘦占10.2%,发育不良占35%。与身高体重相比,STRONGkids对营养不良的检测灵敏度最高(79.4%),特异性高(80.2%);其次是STAMP,敏感性较低(73.5%),特异性较高(81.4%)。PYMS的敏感性最低(66.7%),特异性最高(93.5%),而SAGA的敏感性(77.5%)高于PYMS,特异性较低(85.4%)。结论:使用营养筛查工具评估儿童营养状况是一种有价值的方法,可作为一种简单、快速识别儿童患者营养不良风险的方法。
{"title":"Value of Nutritional Screening Tools Versus Anthropometric Measurements in Evaluating Nutritional Status of Children in a Low/Middle-Income Country.","authors":"Shaimaa Sayed,&nbsp;Mortada H F El-Shabrawi,&nbsp;Eman Abdelmonaem,&nbsp;Nehal El Koofy,&nbsp;Sara Tarek","doi":"10.5223/pghn.2023.26.4.213","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.4.213","url":null,"abstract":"<p><strong>Purpose: </strong>Pediatric patients in low-income countries are at a high risk of malnutrition. Numerous screening tools have been developed to detect the risk of malnutrition, including the Subjective Global Nutritional Assessment (SGNA), Pediatric Yorkhill Malnutrition Score (PYMS), Screening Tool for the Assessment of Malnutrition in Pediatrics (STAMP), and Screening Tool for Risk of Nutritional Status and Growth (STRONGkids). However, anthropometry remains the main tool for assessing malnutrition. We aimed to identify the value of four nutritional screening tools versus anthropometry for evaluating the nutritional status of children.</p><p><strong>Methods: </strong>We conducted a cross-sectional study of 1,000 children aged 1-12 years who visited the outpatient clinic of Cairo University Pediatric Hospital. Each participant was evaluated using anthropometric measurements (weight, length/height, and weight for length/height) as well as the PYMS, STAMP, STRONGkids, and SGNA screening tools. The sensitivities and specificities of these four tools were assessed using anthropometry as the gold standard.</p><p><strong>Results: </strong>Of the patients, 1.7% were underweight, 10.2% were wasted, and 35% were stunted. STRONGkids demonstrated the highest sensitivity (79.4%) and a high specificity (80.2%) for detecting malnutrition compared with weight for height, followed by STAMP, which demonstrated lower sensitivity (73.5%) but higher specificity (81.4%). PYMS demonstrated the lowest sensitivity (66.7%) and the highest specificity (93.5%), whereas SAGA demonstrated higher sensitivity (77.5%) and lower specificity (85.4%) than PYMS.</p><p><strong>Conclusion: </strong>The use of nutritional screening tools to evaluate the nutritional status of children is valuable and recommended as a simple and rapid method for identifying the risk of malnutrition in pediatric patients.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/b5/pghn-26-213.PMC10356972.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9865160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Pediatric Gastroesophageal Reflux Disease Symptom and Quality of Life Questionnaire Score, Endoscopy and Biopsy in Children with Clinical Gastroesophageal Reflux Disease: A Prospective Study. 儿童胃食管反流病症状与临床胃食管反流病儿童生活质量问卷评分、内镜检查和活检的相关性:一项前瞻性研究
IF 1.9 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.5223/pghn.2023.26.4.173
Fatima Safira Alatas, Dian Wulandaru Sukmaning Pertiwi, Muzal Kadim, Pramita Dwipoerwantoro, Hanifah Oswari, Badriul Hegar, Yvan Vandenplas

Purpose: Gastro esophageal reflux disease (GERD) is a burdensome disease affecting many children. A clinical examination is reported to be unreliable to diagnose GERD in children. This study aimed to investigate the relationship between the Pediatric Gastroesophageal Reflux Disease Symptom and Quality of Life Questionnaire (PGSQ) and endoscopic and histopathological findings in children with symptoms suggesting GERD. Changes in the PGSQ score in children with esophagitis as response to one month therapy were recorded as secondary outcome.

Methods: This is a prospective cohort study in the pediatric outpatient clinic in an Indonesian tertiary hospital. Children aged 2-17 years old with clinical symptoms suspected of GERD are included in the study. Blinded endoscopic and histopathological examination was performed in all patients before one month proton pump inhibitors (PPI) therapy. The PGSQ information was collected at inclusion and after one month PPI treatment.

Results: Fifty-eight subjects were included. Esophagitis was found in 60.9% of subjects according to endoscopy and 58.6% according to histology. There was no significant relationship between the PGSQ score and endoscopic (p=0.781) nor biopsy (p=0.740) examinations. The PGSQ showed a low diagnostic value compared to endoscopy and biopsy (area under the curve [AUC] 0.477, p=0.477, 95% confidence interval [CI] 0.326-0.629 and AUC 0.474, p=0.740 (95% CI 0.321-0.627 respectively). The PGSQ improved significantly post one month of PPI treatment.

Conclusion: The PGSQ cannot be used to diagnose esophagitis in children with clinical symptoms suggesting GERD. However, the PGSQ can be used to monitor the treatment response in children with esophagitis.

目的:胃食管反流病(GERD)是一种影响许多儿童的负担性疾病。据报道,临床检查诊断儿童反流是不可靠的。本研究旨在探讨儿童胃食管反流病症状和生活质量问卷(PGSQ)与有胃食管反流症状的儿童的内镜和组织病理学结果之间的关系。食管炎患儿一个月治疗后PGSQ评分的变化作为次要结局记录。方法:这是一项在印度尼西亚三级医院儿科门诊进行的前瞻性队列研究。年龄在2-17岁、有疑似胃食管反流临床症状的儿童被纳入研究。所有患者在质子泵抑制剂(PPI)治疗前一个月进行盲法内镜和组织病理学检查。在纳入时和PPI治疗1个月后收集PGSQ信息。结果:共纳入58名受试者。内镜检查食管炎发生率为60.9%,组织学检查为58.6%。PGSQ评分与内镜检查(p=0.781)和活检检查(p=0.740)无显著相关性。与内镜检查和活检相比,PGSQ的诊断价值较低(曲线下面积[AUC] 0.477, p=0.477, 95%可信区间[CI] 0.326 ~ 0.629, AUC 0.474, p=0.740 (95% CI分别为0.321 ~ 0.627)。PPI治疗1个月后,PGSQ显著改善。结论:PGSQ不能用于诊断食管炎的临床症状为反流。然而,PGSQ可用于监测儿童食管炎的治疗反应。
{"title":"Association Between Pediatric Gastroesophageal Reflux Disease Symptom and Quality of Life Questionnaire Score, Endoscopy and Biopsy in Children with Clinical Gastroesophageal Reflux Disease: A Prospective Study.","authors":"Fatima Safira Alatas,&nbsp;Dian Wulandaru Sukmaning Pertiwi,&nbsp;Muzal Kadim,&nbsp;Pramita Dwipoerwantoro,&nbsp;Hanifah Oswari,&nbsp;Badriul Hegar,&nbsp;Yvan Vandenplas","doi":"10.5223/pghn.2023.26.4.173","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.4.173","url":null,"abstract":"<p><strong>Purpose: </strong>Gastro esophageal reflux disease (GERD) is a burdensome disease affecting many children. A clinical examination is reported to be unreliable to diagnose GERD in children. This study aimed to investigate the relationship between the Pediatric Gastroesophageal Reflux Disease Symptom and Quality of Life Questionnaire (PGSQ) and endoscopic and histopathological findings in children with symptoms suggesting GERD. Changes in the PGSQ score in children with esophagitis as response to one month therapy were recorded as secondary outcome.</p><p><strong>Methods: </strong>This is a prospective cohort study in the pediatric outpatient clinic in an Indonesian tertiary hospital. Children aged 2-17 years old with clinical symptoms suspected of GERD are included in the study. Blinded endoscopic and histopathological examination was performed in all patients before one month proton pump inhibitors (PPI) therapy. The PGSQ information was collected at inclusion and after one month PPI treatment.</p><p><strong>Results: </strong>Fifty-eight subjects were included. Esophagitis was found in 60.9% of subjects according to endoscopy and 58.6% according to histology. There was no significant relationship between the PGSQ score and endoscopic (<i>p</i>=0.781) nor biopsy (<i>p</i>=0.740) examinations. The PGSQ showed a low diagnostic value compared to endoscopy and biopsy (area under the curve [AUC] 0.477, <i>p</i>=0.477, 95% confidence interval [CI] 0.326-0.629 and AUC 0.474, <i>p</i>=0.740 (95% CI 0.321-0.627 respectively). The PGSQ improved significantly post one month of PPI treatment.</p><p><strong>Conclusion: </strong>The PGSQ cannot be used to diagnose esophagitis in children with clinical symptoms suggesting GERD. However, the PGSQ can be used to monitor the treatment response in children with esophagitis.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/47/4c/pghn-26-173.PMC10356974.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9918959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Immunodeficiencies in Children Initially Admitted with Gastrointestinal/Liver Manifestations. 以胃肠道/肝脏表现入院儿童的原发性免疫缺陷
IF 1.9 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.5223/pghn.2023.26.4.201
Murat Cakir, Nalan Yakici, Elif Sag, Gulay Kaya, Ayşenur Bahadir, Alper Han Cebi, Fazil Orhan

Purpose: The gastrointestinal system is the most commonly affected organ, followed by the lungs, in patients with primary immunodeficiency disease (PID). Hence, it is common for children with PIDs to present with gastrointestinal symptoms. We aimed to analyze the clinical and histopathological findings of patients who were initially admitted to pediatric gastroenterology/hepatology clinics and subsequently diagnosed with PIDs to identify the clinical clues for PIDs.

Methods: The demographic, laboratory, and histopathological findings, treatment modality, and outcomes of patients initially admitted to the pediatric gastroenterology/hepatology unit and subsequently diagnosed with PIDs were recorded.

Results: The study included 24 patients (58.3% male; median age [range]: 29 [0.5-204] months). Common clinical presentations included chronic diarrhea (n=8), colitis (n=6), acute hepatitis (n=4), and acute liver failure (n=2). The association of autoimmune diseases, development of malignant diseases, and severe progression of viral diseases was observed in 20.8%, 8.3%, and 16.6% of the patients, respectively. Antibody deficiency was predominantly diagnosed in 29.2% of patients, combined immunodeficiency in 20.8%, immune dysregulation in 12.5%, defects in intrinsic and innate immunity in 4.2%, autoinflammatory disorders in 8.3%, and congenital defects of phagocytes in 4.2%. Five patients remained unclassified (20.8%).

Conclusion: Patients with PIDs may initially experience gastrointestinal or liver problems. It is recommended that the association of autoimmune or malignant diseases or severe progression of viral diseases provide pediatric gastroenterologists some suspicion of PIDs. After screening using basic laboratory tests, genetic analysis is mandatory for a definitive diagnosis.

目的:在原发性免疫缺陷病(PID)患者中,胃肠道系统是最常见的受累器官,其次是肺。因此,患有pid的儿童通常会出现胃肠道症状。我们的目的是分析最初入住儿科胃肠病学/肝脏病学诊所并随后诊断为PIDs的患者的临床和组织病理学表现,以确定PIDs的临床线索。方法:记录最初入住儿科胃肠病学/肝病科并随后诊断为pid的患者的人口学、实验室和组织病理学结果、治疗方式和结局。结果:纳入24例患者,其中男性58.3%;中位年龄[范围]:29[0.5-204]个月)。常见的临床表现包括慢性腹泻(n=8)、结肠炎(n=6)、急性肝炎(n=4)和急性肝衰竭(n=2)。自身免疫性疾病、恶性疾病发展和病毒性疾病严重进展的相关性分别为20.8%、8.3%和16.6%。29.2%的患者主要诊断为抗体缺乏,20.8%的患者诊断为联合免疫缺陷,12.5%的患者诊断为免疫失调,4.2%的患者诊断为固有免疫和先天免疫缺陷,8.3%的患者诊断为自身炎症性疾病,4.2%的患者诊断为先天性吞噬细胞缺陷。5例患者未分类(20.8%)。结论:pid患者最初可能出现胃肠道或肝脏问题。建议与自身免疫性疾病或恶性疾病或病毒性疾病严重进展的关联,为儿科胃肠病学家提供一些对pid的怀疑。在使用基本实验室测试进行筛选后,必须进行基因分析以确定诊断。
{"title":"Primary Immunodeficiencies in Children Initially Admitted with Gastrointestinal/Liver Manifestations.","authors":"Murat Cakir,&nbsp;Nalan Yakici,&nbsp;Elif Sag,&nbsp;Gulay Kaya,&nbsp;Ayşenur Bahadir,&nbsp;Alper Han Cebi,&nbsp;Fazil Orhan","doi":"10.5223/pghn.2023.26.4.201","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.4.201","url":null,"abstract":"<p><strong>Purpose: </strong>The gastrointestinal system is the most commonly affected organ, followed by the lungs, in patients with primary immunodeficiency disease (PID). Hence, it is common for children with PIDs to present with gastrointestinal symptoms. We aimed to analyze the clinical and histopathological findings of patients who were initially admitted to pediatric gastroenterology/hepatology clinics and subsequently diagnosed with PIDs to identify the clinical clues for PIDs.</p><p><strong>Methods: </strong>The demographic, laboratory, and histopathological findings, treatment modality, and outcomes of patients initially admitted to the pediatric gastroenterology/hepatology unit and subsequently diagnosed with PIDs were recorded.</p><p><strong>Results: </strong>The study included 24 patients (58.3% male; median age [range]: 29 [0.5-204] months). Common clinical presentations included chronic diarrhea (n=8), colitis (n=6), acute hepatitis (n=4), and acute liver failure (n=2). The association of autoimmune diseases, development of malignant diseases, and severe progression of viral diseases was observed in 20.8%, 8.3%, and 16.6% of the patients, respectively. Antibody deficiency was predominantly diagnosed in 29.2% of patients, combined immunodeficiency in 20.8%, immune dysregulation in 12.5%, defects in intrinsic and innate immunity in 4.2%, autoinflammatory disorders in 8.3%, and congenital defects of phagocytes in 4.2%. Five patients remained unclassified (20.8%).</p><p><strong>Conclusion: </strong>Patients with PIDs may initially experience gastrointestinal or liver problems. It is recommended that the association of autoimmune or malignant diseases or severe progression of viral diseases provide pediatric gastroenterologists some suspicion of PIDs. After screening using basic laboratory tests, genetic analysis is mandatory for a definitive diagnosis.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/98/pghn-26-201.PMC10356973.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9865162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of Contrast Enhanced Ultrasound and Elastography in the Early Detection of Fibro-Stenotic Ileal Strictures in Children with Crohn's Disease. 对比增强超声和弹性成像在克罗恩病儿童纤维狭窄性回肠狭窄早期检测中的应用
IF 1.9 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.5223/pghn.2023.26.4.193
Sarah D Sidhu, Shelly Joseph, Emily Dunn, Carmen Cuffari

Purpose: Crohn's disease (CD) is a chronic, idiopathic bowel disorder that can progress to partial or complete bowel obstruction. At present, there are no reliable diagnostic tests that can readily distinguish between acute inflammatory, purely fibrotic and mixed inflammatory and fibrotic. Our aim is to study the utility of contrast enhanced ultrasound (CEUS) in combination with shear wave elastography (SWE) to differentiate fibrotic from inflammatory strictures in children with obstructive CD of the terminal ileum.

Methods: Twenty-five (19 male) children between 2016-2021 with CD of the terminal ileum were recruited into the study. Among these patients, 22 had CEUS kinetic measurements of tissue perfusion, including wash-in slope (dB/sec), peak intensity (dB), time to peak intensity (sec), area under the curve (AUC) (dB sec), and SWE. In total, 11 patients required surgery due to bowel obstruction. Histopathologic analysis was performed by a pathologist who was blinded to the CEUS and SWE test results.

Results: Patients that underwent surgical resection had significantly higher mean area under the curve on CEUS compared to patients responsive to medical therapy (p=0.03). The AUC also correlated with the degree of hypertrophy and the percent fibrosis of the muscularis propria, as determined by histopathologic grading (p<0.01). There was no difference in the mean elastography measurements between these two patient groups.

Conclusion: CEUS is a useful radiological technique that can help identify pediatric patients with medically refractory obstructive fibrotic strictures of the terminal ileum that should be considered for early surgical resection.

目的:克罗恩病(CD)是一种慢性,特发性肠道疾病,可进展为部分或完全肠梗阻。目前,还没有可靠的诊断试验,可以很容易地区分急性炎症、纯粹纤维化和混合性炎症和纤维化。我们的目的是研究对比增强超声(CEUS)结合剪切波弹性成像(SWE)对儿童回肠末端梗阻性CD纤维化和炎性狭窄的鉴别价值。方法:研究招募了25名(19名男性)2016-2021年间患有回肠末端CD的儿童。在这些患者中,22例进行了超声造影组织灌注动力学测量,包括冲洗斜率(dB/sec)、峰值强度(dB)、至峰值强度时间(sec)、曲线下面积(AUC) (dB sec)和SWE。共有11例患者因肠梗阻需要手术。组织病理学分析由病理学家进行,他对超声造影和SWE测试结果不知情。结果:手术切除的患者超声造影曲线下平均面积明显高于药物治疗的患者(p=0.03)。AUC还与肥大程度和固有肌层纤维化百分比相关,这是由组织病理学分级确定的。结论:超声造影是一种有用的放射学技术,可以帮助识别医学上难治性回肠末端梗阻性纤维化狭窄的儿科患者,这些患者应该考虑早期手术切除。
{"title":"The Utility of Contrast Enhanced Ultrasound and Elastography in the Early Detection of Fibro-Stenotic Ileal Strictures in Children with Crohn's Disease.","authors":"Sarah D Sidhu,&nbsp;Shelly Joseph,&nbsp;Emily Dunn,&nbsp;Carmen Cuffari","doi":"10.5223/pghn.2023.26.4.193","DOIUrl":"https://doi.org/10.5223/pghn.2023.26.4.193","url":null,"abstract":"<p><strong>Purpose: </strong>Crohn's disease (CD) is a chronic, idiopathic bowel disorder that can progress to partial or complete bowel obstruction. At present, there are no reliable diagnostic tests that can readily distinguish between acute inflammatory, purely fibrotic and mixed inflammatory and fibrotic. Our aim is to study the utility of contrast enhanced ultrasound (CEUS) in combination with shear wave elastography (SWE) to differentiate fibrotic from inflammatory strictures in children with obstructive CD of the terminal ileum.</p><p><strong>Methods: </strong>Twenty-five (19 male) children between 2016-2021 with CD of the terminal ileum were recruited into the study. Among these patients, 22 had CEUS kinetic measurements of tissue perfusion, including wash-in slope (dB/sec), peak intensity (dB), time to peak intensity (sec), area under the curve (AUC) (dB sec), and SWE. In total, 11 patients required surgery due to bowel obstruction. Histopathologic analysis was performed by a pathologist who was blinded to the CEUS and SWE test results.</p><p><strong>Results: </strong>Patients that underwent surgical resection had significantly higher mean area under the curve on CEUS compared to patients responsive to medical therapy (<i>p</i>=0.03). The AUC also correlated with the degree of hypertrophy and the percent fibrosis of the muscularis propria, as determined by histopathologic grading (<i>p</i><0.01). There was no difference in the mean elastography measurements between these two patient groups.</p><p><strong>Conclusion: </strong>CEUS is a useful radiological technique that can help identify pediatric patients with medically refractory obstructive fibrotic strictures of the terminal ileum that should be considered for early surgical resection.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/29/e1/pghn-26-193.PMC10356970.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9865165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Gastroenterology, Hepatology & Nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1